Cargando…
Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)‐induced nephropathy, a typ...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876505/ https://www.ncbi.nlm.nih.gov/pubmed/33448693 http://dx.doi.org/10.1002/2211-5463.13083 |
_version_ | 1783649988437344256 |
---|---|
author | Ishii, Takeo Kumagae, Tomohiro Wakui, Hiromichi Urate, Shingo Tanaka, Shohei Abe, Eriko Suzuki, Toru Yamaji, Takahiro Kinguchi, Sho Kobayashi, Ryu Haruhara, Kotaro Nakamura, Takashi Kobayashi, Shuzo Tamura, Kouichi |
author_facet | Ishii, Takeo Kumagae, Tomohiro Wakui, Hiromichi Urate, Shingo Tanaka, Shohei Abe, Eriko Suzuki, Toru Yamaji, Takahiro Kinguchi, Sho Kobayashi, Ryu Haruhara, Kotaro Nakamura, Takashi Kobayashi, Shuzo Tamura, Kouichi |
author_sort | Ishii, Takeo |
collection | PubMed |
description | Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)‐induced nephropathy, a type of nephrotoxic chronic kidney disease (CKD). A persistent decrease in renal function was observed in mice up to 4 weeks after 4 weeks of AA (2.5 mg kg(−1)) administration. Renal histology revealed an increase in tubular interstitial fibrosis over time. Although AA administration did not change XOR activity in the plasma, heart, liver, or muscle, XOR activity was persistently increased in renal tissue. Our results suggest that the renal tissue‐specific increase in XOR activity is involved in the progression of tubulo‐interstitial disorders, specifically fibrosis. |
format | Online Article Text |
id | pubmed-7876505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78765052021-02-18 Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy Ishii, Takeo Kumagae, Tomohiro Wakui, Hiromichi Urate, Shingo Tanaka, Shohei Abe, Eriko Suzuki, Toru Yamaji, Takahiro Kinguchi, Sho Kobayashi, Ryu Haruhara, Kotaro Nakamura, Takashi Kobayashi, Shuzo Tamura, Kouichi FEBS Open Bio Research Articles Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)‐induced nephropathy, a type of nephrotoxic chronic kidney disease (CKD). A persistent decrease in renal function was observed in mice up to 4 weeks after 4 weeks of AA (2.5 mg kg(−1)) administration. Renal histology revealed an increase in tubular interstitial fibrosis over time. Although AA administration did not change XOR activity in the plasma, heart, liver, or muscle, XOR activity was persistently increased in renal tissue. Our results suggest that the renal tissue‐specific increase in XOR activity is involved in the progression of tubulo‐interstitial disorders, specifically fibrosis. John Wiley and Sons Inc. 2021-02-01 /pmc/articles/PMC7876505/ /pubmed/33448693 http://dx.doi.org/10.1002/2211-5463.13083 Text en © 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Ishii, Takeo Kumagae, Tomohiro Wakui, Hiromichi Urate, Shingo Tanaka, Shohei Abe, Eriko Suzuki, Toru Yamaji, Takahiro Kinguchi, Sho Kobayashi, Ryu Haruhara, Kotaro Nakamura, Takashi Kobayashi, Shuzo Tamura, Kouichi Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
title | Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
title_full | Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
title_fullStr | Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
title_full_unstemmed | Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
title_short | Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
title_sort | tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876505/ https://www.ncbi.nlm.nih.gov/pubmed/33448693 http://dx.doi.org/10.1002/2211-5463.13083 |
work_keys_str_mv | AT ishiitakeo tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT kumagaetomohiro tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT wakuihiromichi tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT urateshingo tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT tanakashohei tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT abeeriko tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT suzukitoru tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT yamajitakahiro tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT kinguchisho tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT kobayashiryu tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT haruharakotaro tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT nakamuratakashi tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT kobayashishuzo tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy AT tamurakouichi tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy |